6-1611567-GGGCGGCGGC-GGGCGGC
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_001453.3(FOXC1):c.1139_1141delGCG(p.Gly380del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000431 in 1,141,794 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. G380G) has been classified as Likely benign.
Frequency
Consequence
NM_001453.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Publications
- anterior segment dysgenesis 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- Axenfeld-Rieger syndrome type 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- aniridiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- Axenfeld anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Axenfeld-Rieger syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated aniridiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Peters anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Rieger anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FOXC1 | NM_001453.3 | c.1139_1141delGCG | p.Gly380del | disruptive_inframe_deletion | Exon 1 of 1 | ENST00000645831.2 | NP_001444.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FOXC1 | ENST00000645831.2 | c.1139_1141delGCG | p.Gly380del | disruptive_inframe_deletion | Exon 1 of 1 | NM_001453.3 | ENSP00000493906.1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 24AN: 146422Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.000590 AC: 8AN: 13566 AF XY: 0.000676 show subpopulations
GnomAD4 exome AF: 0.000470 AC: 468AN: 995372Hom.: 2 AF XY: 0.000530 AC XY: 252AN XY: 475402 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000164 AC: 24AN: 146422Hom.: 0 Cov.: 24 AF XY: 0.000155 AC XY: 11AN XY: 71196 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
- -
Axenfeld-Rieger syndrome type 3 Uncertain:1
This variant, c.1139_1141del, results in the deletion of 1 amino acid(s) of the FOXC1 protein (p.Gly380del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with FOXC1-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
FOXC1-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at